Horwell Edward, Bearn Philip, Cutting Simon M
Department of Biomedical Sciences, The Bourne Laboratory, Royal Holloway University of London, London TW20 0EX, UK.
Department of Colorectal Surgery, Ashford and Saint Peter's NHS Foundation Trust, London KT16 0PZ, UK.
Microbiome Res Rep. 2024 Sep 24;4(1):1. doi: 10.20517/mrr.2024.32. eCollection 2025.
Since the advent of new sequencing and bioinformatic technologies, our understanding of the human microbiome has expanded rapidly over recent years. Numerous studies have indicated causal links between alterations to the microbiome and a range of pathological conditions. Furthermore, a large body of epidemiological data is starting to suggest that exposure, or lack thereof, to specific microbial species during the first five years of life has key implications for long-term health outcomes. These include chronic inflammatory and metabolic conditions such as diabetes, asthma, inflammatory bowel disease (IBD), and obesity, with the effects lasting into adulthood. Human microbial colonisation during these first five years of life is a highly dynamic process, with multiple environmental exposures recently being characterised to have influence before the microbiome stabilises and resembles that of an adult at 3-5 years. This short period of time, known as the window of opportunity, appears to "prime" immunoregulation for later life. Understanding and appreciating this aspect of human physiology is therefore crucial for clinicians, scientists, and public health officials. This review outlines the most recent evidence for the pre- and post-natal environments that order the development of the microbiome, how these influences metabolic and immunoregulatory pathways, and their associated health outcomes. It also discusses the limitations of the current knowledge base, and describes the potential microbiome-mediated interventions and public health measures that may have therapeutic potential in the future.
自新的测序和生物信息学技术问世以来,近年来我们对人类微生物组的理解迅速扩展。大量研究表明微生物组的改变与一系列病理状况之间存在因果联系。此外,大量流行病学数据开始表明,生命最初五年中接触特定微生物物种与否,对长期健康结果具有关键影响。这些影响包括糖尿病、哮喘、炎症性肠病(IBD)和肥胖等慢性炎症和代谢性疾病,其影响会持续到成年期。在生命的最初五年中,人类微生物定殖是一个高度动态的过程,最近有多种环境暴露因素被确定在微生物组稳定并在3至5岁时类似成年人微生物组之前就具有影响。这段短暂的时间,即所谓的机遇之窗,似乎为后期生命的免疫调节“奠定基础”。因此,对于临床医生、科学家和公共卫生官员来说,理解和认识人类生理学的这一方面至关重要。本综述概述了有关产前和产后环境影响微生物组发育的最新证据,这些环境如何影响代谢和免疫调节途径及其相关的健康结果。它还讨论了当前知识库的局限性,并描述了未来可能具有治疗潜力的微生物组介导的干预措施和公共卫生措施。